Home › NDC Lookup › RxCUI directory › RxCUI 1540241

Benzoyl peroxide 0.05 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel — RxCUI 1540241

RxNorm drug concept · Semantic clinical drug
RxCUI 1540241 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1540241
Official nameBenzoyl peroxide 0.05 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbenzoyl peroxide 5 % / clindamycin phosphate 1.2 % Topical Gel
FDA products mapped6
Package NDCs mapped6
Reported Medicaid activity (SDUD)111,340 prescriptions · 44 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Benzoyl Peroxide Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Over-the-counter products are used for acne. The prescription product EPSOLAY is used for inflammatory lesions of rosacea in adults.
  • Do a test on one or two small areas for the first 3 days if you are new to an over-the-counter product. If it feels fine, apply a thin layer once daily and increase to two or three...
  • Redness, dryness, peeling, itching and burning or stinging are common. Using it less often can help. Stop and call your doctor if irritation becomes severe.
  • It's best not to. Using more than one topical acne medicine at a time makes irritation and dryness more likely. If irritation develops, use only one.
📖 Read our full Benzoyl Peroxide Topical guide →

🕸️ Concept Web — How Benzoyl peroxide 0.05 MG/MG / clindamycin phosph... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Benzoyl peroxide 0.05 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel RxCUI 1540241

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Benzoyl peroxide 1418
    • Clindamycin 2582
    • Benzoyl peroxide / clindamycin 646781
    • Clindamycin phosphate 797272
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Neuac 1540242
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Benzoyl peroxide / clindamycin Topical Gel 379074
    • Benzoyl peroxide / clindamycin phosphate Topical Gel 2647031
    • Benzoyl peroxide / clindamycin Topical Product 1152978
    • Benzoyl peroxide / clindamycin phosphate Topical Product 2662222
    • Benzoyl peroxide / clindamycin Topical Gel [Neuac] 1540244
    • Benzoyl peroxide / clindamycin phosphate Topical Gel [Neuac] 2656225
    • Neuac Topical Product 1540245
    • Topical Gel 346286
    • +1 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 17 of 18 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Benzoyl peroxide 0.05 MG/MG SCDC · 328718
  • Clindamycin phosphate 0.012 MG/MG SCDC · 882547
  • Benzoyl peroxide / clindamycin Topical Gel SCDF · 379074
  • Benzoyl peroxide / clindamycin phosphate Topical Gel SCDFP · 2647031
  • Benzoyl peroxide / clindamycin Topical Product SCDG · 1152978
  • Benzoyl peroxide / clindamycin phosphate Topical Product SCDGP · 2662222

Brand-Name Concepts

📦 FDA Products & Package NDCs

6 products · 6 package NDCs
6 package NDCs map to RxCUI 1540241 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
21922-0022-06 1 TUBE in 1 CARTON (21922-022-06) / 45 g in 1 TUBE CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE Encube Ethicals, Inc. 2021-05-20
43538-0176-45 1 TUBE in 1 CARTON (43538-176-45) / 45 g in 1 TUBE Neuac Medimetriks Pharmaceuticals 2014-06-15
45802-0736-84 1 TUBE in 1 CARTON (45802-736-84) / 45 g in 1 TUBE clindamycin phosphate and benzoyl peroxide Padagis Israel Pharmaceuticals Ltd 2012-06-26
70710-1445-04 1 TUBE in 1 CARTON (70710-1445-4) / 45 g in 1 TUBE Clindamycin Phosphate and Benzoyl Peroxide Zydus Pharmaceuticals USA Inc. 2019-03-07
71335-2878-01 1 TUBE in 1 CARTON (71335-2878-1) / 45 g in 1 TUBE CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE Bryant Ranch Prepack 2025-10-22
72162-2299-02 1 TUBE in 1 CARTON (72162-2299-2) / 45 g in 1 TUBE CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE Bryant Ranch Prepack 2024-04-30
Observed labelers: Bryant Ranch Prepack (2) · Encube Ethicals, Inc. (1) · Medimetriks Pharmaceuticals (1) · Padagis Israel Pharmaceuticals Ltd (1) · Zydus Pharmaceuticals USA Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per gm · median
$0.4030
Range $0.4030–$0.4030 · middle 50% $0.4030–$0.4030 · 3 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.